Quest Diagnostics Shares Outstanding 2010-2024 | DGX

Quest Diagnostics shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Quest Diagnostics shares outstanding for the quarter ending September 30, 2024 were 0.113B, a 0.88% decline year-over-year.
  • Quest Diagnostics 2023 shares outstanding were 0.113B, a 4.24% decline from 2022.
  • Quest Diagnostics 2022 shares outstanding were 0.118B, a 7.81% decline from 2021.
  • Quest Diagnostics 2021 shares outstanding were 0.128B, a 5.88% decline from 2020.
Quest Diagnostics Annual Shares Outstanding
(Millions of Shares)
2023 113
2022 118
2021 128
2020 136
2019 136
2018 139
2017 140
2016 142
2015 145
2014 145
2013 153
2012 160
2011 160
2010 177
2009 188
Quest Diagnostics Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 113
2024-06-30 112
2024-03-31 112
2023-12-31 113
2023-09-30 114
2023-06-30 114
2023-03-31 113
2022-12-31 118
2022-09-30 118
2022-06-30 119
2022-03-31 121
2021-12-31 128
2021-09-30 125
2021-06-30 127
2021-03-31 135
2020-12-31 136
2020-09-30 137
2020-06-30 136
2020-03-31 135
2019-12-31 136
2019-09-30 137
2019-06-30 136
2019-03-31 136
2018-12-31 139
2018-09-30 139
2018-06-30 139
2018-03-31 139
2017-12-31 140
2017-09-30 140
2017-06-30 140
2017-03-31 141
2016-12-31 142
2016-09-30 142
2016-06-30 142
2016-03-31 144
2015-12-31 145
2015-09-30 145
2015-06-30 145
2015-03-31 146
2014-12-31 145
2014-09-30 145
2014-06-30 145
2014-03-31 145
2013-12-31 153
2013-09-30 151
2013-06-30 154
2013-03-31 159
2012-12-31 160
2012-09-30 161
2012-06-30 160
2012-03-31 160
2011-12-31 160
2011-09-30 159
2011-06-30 159
2011-03-31 161
2010-12-31 177
2010-09-30 174
2010-06-30 181
2010-03-31 182
2009-12-31 188
2009-09-30 187
2009-06-30 187
2009-03-31 191
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.988B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00